GENTEN THERAPEUTICS
Genten Therapeutics develops a monotherapy through an antigen specific induction of immune tolerance for gluten. The company was incorporated in 2016 and is based in San Francisco, California.
GENTEN THERAPEUTICS
Industry:
Biotechnology Life Science Medical
Founded:
2016-01-01
Address:
San Francisco, California, United States
Country:
United States
Total Employee:
1+
Status:
Active
Contact:
(415)835-3900
Total Funding:
12 M USD
Similar Organizations
SmartPharm Therapeutics
SmartPharm Therapeutics is a second-generation gene-encoded therapeutics company.
Current Employees Featured
More informations about "Genten Therapeutics"
Genten Therapeutics Company Profile 2025: Valuation, Funding ...
Genten Therapeutics General Information Description. Developer of gluten-free supplements designed to provide therapies for celiac disease. The company specializes in providing …See details»
Genten Therapeutics - Funding, Financials, Valuation & Investors
Genten Therapeutics is a provider a monotherapy through an antigen specific induction. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. ... How …See details»
GENTEN THERAPEUTICS, INC. :: California (US) - OpenCorporates
GENTEN THERAPEUTICS, INC. branch. Company Number 3946075 Previous Company Numbers. C3946075; Status Active Incorporation Date 16 September 2016 (about 6 years …See details»
Genten Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Genten Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Research programme: autoimmune therapies - Genten …
Genten Therapeutics is developing gluten peptides, alone or in combination with immunomodulatory cytokines, utilising Precigen Inc (formerly Intrexon Research programme: …See details»
Genten Therapeutics - Contacts, Employees, Board Members
Genten Therapeutics is a provider a monotherapy through an antigen specific induction.See details»
Genten Therapeutics, Inc. in San Francisco, California - EIN TaxId
Genten Therapeutics, Inc. is a corporation in San Francisco, California. The employer identification number (EIN) for Genten Therapeutics, Inc. is 813858436. EIN for organizations …See details»
Genten Therapeutics Company Profile -Sales, Contacts, …
Genten Therapeutics is in the Biotechnical Research, Commercial industry within the Engineering, Accounting, Research, and Management Services sector and has been in business for …See details»
GENTEN THERAPEUTICS INC San Francisco CA, 94111 - Company …
Free Business profile for GENTEN THERAPEUTICS INC at 600 Montgomery St, San Francisco, CA, 94111-2719, US. GENTEN THERAPEUTICS INC specializes in: Commercial Physical …See details»
Genten Therapeutics - Products, Competitors, Financials, …
Genten Therapeutics' goal is to deliver a monotherapy through an antigen-specific induction of immune tolerance for gluten to address this high unmet medical need. "Celiac disease …See details»
Intrexon partners with a pair of its fund portfolio startups
Sep 23, 2016 Now, it’s done deals with two of the portfolio companies backed by the fund: Genten Therapeutics, which is focused on gluten peptide expression, and CRS Bio, which …See details»
GENTEN THERAPEUTICS INC Germantown MD, 20876 - Company …
Free Business profile for GENTEN THERAPEUTICS INC at 20374 Seneca Meadows Pkwy, Germantown, MD, 20876-7004, US. GENTEN THERAPEUTICS INC specializes in: …See details»
Genten Therapeutics | Solt DB Biotech Company Database
Genten Therapeutics. Solt DB Biotech Company DB / Genten Therapeutics. Solt_DB. Genten Therapeutics. Operating Overview. Year Founded. 2016. Country. United States. Operating …See details»
Genten Therapeutics - Crunchbase
Genten Therapeutics is a provider a monotherapy through an antigen specific induction.See details»
Genten Therapeutics - aVenture Company Research
Genten Therapeutics, founded in 2016, develops gluten-tolerance monotherapy via antigen-specific induction.See details»
813858436 EIN/TAX ID | GENTEN THERAPEUTICS, INC. - HIPAASpace
GENTEN THERAPEUTICS, INC. Conformed submission company name, business name, organization name, etc CIK: 0001685989: Company's Central Index Key (CIK). The Central …See details»
Intrexon to Develop Disease-Modifying Therapies in New …
Sep 23, 2016 Genten Therapeutics, Inc. will center efforts on ActoBiotics ™ expression of gluten peptides, alone or in combination with immunomodulatory cytokines, to reestablish immune …See details»
Highlighting 25 Top Cancer Gene Therapy Companies - Inven
KSQ Therapeutics is a biotechnology company specializing in CRISPRomics for immuno-oncology therapies. They have developed autologous cell therapy candidates, KSQ-001 and …See details»
Genten Therapeutics - Updates, News, Events, Signals & Triggers
Oct 3, 2016 Organization. Genten Therapeutics . Connect to CRM . Save . Summary. Financials. People. Signals & News ... Edit Recent News & Activity Section. Funding Round • Oct 3, 2016. …See details»
Genenta Strengthens Agreement with AGC Biologics to Boost Cell …
3 days ago MILAN and NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, is …See details»